SENSEX
NIFTY
GOLD
USD/INR

Weather

image 20    C

Economy News

The Economic Times

Economy / The Economic Times

details

Assessing products to counter side effects of GLP-1, says Bayer's Triana

Bayer AG plans to expand its consumer health business in India significantly by 2030. The company aims to triple its revenue in the Indian market during this period. Bayer is specifically targeting opportunities in digestive health, nutrition, and multivitamins related to GLP-1 drug side effects. Additionally, Bayer will develop products locally and seek manufacturing partnerships to enhance their market presence.

12 Oct 2026 1:33 am